IFP Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.18K | Buy |
349
+105
| +43% | +$871 | ﹤0.01% | 3888 |
|
|
2026
Q1 | $2.04K | Sell |
244
-385
| -61% | -$4.04K | ﹤0.01% | 3954 |
|
|
2025
Q4 | $9.06K | Buy |
629
+284
| +82% | +$3.54K | ﹤0.01% | 3118 |
|
|
2025
Q3 | $3.33K | Buy |
345
+158
| +84% | +$1.4K | ﹤0.01% | 3465 |
|
|
2025
Q2 | $1.53K | Buy |
187
+163
| +679% | +$1.36K | ﹤0.01% | 4018 |
|
|
2025
Q1 | $172 | Hold |
24
| – | – | ﹤0.01% | 3709 |
|
|
2024
Q4 | $186 | Buy |
+24
| New | +$225 | ﹤0.01% | 3785 |
|
|
2024
Q2 | – | Sell |
-125
| Closed | -$2.63K | – | 3325 |
|
|
2024
Q1 | $2.63K | Hold |
125
| – | – | ﹤0.01% | 2624 |
|
|
2023
Q4 | $2.24K | Hold |
125
| – | – | ﹤0.01% | 2654 |
|
|
2023
Q3 | $2.06K | Hold |
125
| – | – | ﹤0.01% | 2829 |
|
|
2023
Q2 | $2.5K | Hold |
125
| – | – | ﹤0.01% | 2803 |
|
|
2023
Q1 | $6.71K | Sell |
125
-17
| -12% | -$376 | ﹤0.01% | 2452 |
|
|
2022
Q4 | $10K | Sell |
142
-75
| -35% | -$1.7K | ﹤0.01% | 3403 |
|
|
2022
Q3 | $14K | Buy |
217
+17
| +9% | +$504 | ﹤0.01% | 3405 |
|
|
2022
Q2 | $11K | Hold |
200
| – | – | ﹤0.01% | 3345 |
|
|
2022
Q1 | $11K | Hold |
200
| – | – | ﹤0.01% | 3344 |
|
|
2021
Q4 | $7K | Hold |
200
| – | – | ﹤0.01% | 2360 |
|
|
2021
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 2374 |
|
|
2021
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 2303 |
|
|
2021
Q1 | $7K | Hold |
200
| – | – | ﹤0.01% | 2288 |
|
|
2020
Q4 | $9K | Hold |
200
| – | – | ﹤0.01% | 2112 |
|
|
2020
Q3 | $6K | Hold |
200
| – | – | ﹤0.01% | 2116 |
|
|
2020
Q2 | $7K | Hold |
200
| – | – | ﹤0.01% | 1959 |
|
|
2020
Q1 | $7K | Sell |
200
-1,064
| -84% | -$44.3K | ﹤0.01% | 1941 |
|
|
2019
Q4 | $52K | Buy |
1,264
+1,064
| +532% | +$42K | ﹤0.01% | 1237 |
|
|
2019
Q3 | $7K | Buy |
+200
| New | +$8.1K | ﹤0.01% | 2232 |
|
|
2019
Q1 | $9K | Sell |
150
-325
| -68% | -$16.1K | ﹤0.01% | 1669 |
|
|
2018
Q4 | $20K | Hold |
475
| – | – | ﹤0.01% | 2144 |
|
|
2018
Q3 | $36K | Hold |
475
| – | – | ﹤0.01% | 2087 |
|
|
2018
Q2 | $34K | Hold |
475
| – | – | ﹤0.01% | 2147 |
|
|
2018
Q1 | $16K | Hold |
475
| – | – | ﹤0.01% | 2532 |
|
|
2017
Q4 | $16K | Buy |
475
+100
| +27% | +$3.01K | ﹤0.01% | 2568 |
|
|
2017
Q3 | $12K | Buy |
+375
| New | +$8.44K | ﹤0.01% | 2932 |
|
|
2016
Q2 | – | Sell |
-150
| Closed | -$9K | – | 4030 |
|
|
2016
Q1 | $9K | Buy |
+150
| New | +$1.92K | ﹤0.01% | 1667 |
|
Other funds holding RGNX
RG
IFP Advisors's RGNX Position: Q2 2026 in Review
IFP Advisors increased its Regenxbio (RGNX) stake by 43% in Q2 2026, buying an estimated $871 and bringing the position to 349 shares worth $4.18K. The position accounts for ﹤0.01% of the portfolio, ranked #3888.
IFP Advisors first reported a position in RGNX in Q1 2016 and has held it in 34 quarters since. The position peaked at $52K in Q4 2019. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- IFP Advisors held 349 shares of Regenxbio worth $4.18K as of Q2 2026.
- IFP Advisors bought 105 Regenxbio shares in Q2 2026, an estimated $871.
- Regenxbio made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3888 holding.
- IFP Advisors first reported a position in Regenxbio in Q1 2016 and has held it in 34 quarters since.
- IFP Advisors's Regenxbio position peaked at $52K in Q4 2019.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.